Technology
Preci has developed propietary flexible technology allowing the generation of human-derived ECM models applicable for the wide range of organ systems. Over the time we have generated the range of the products, including cancer-derived ECM hydrogels, liver-derived ECM hydrogels, etc.
Low ischemia human tissue is carefully collected from the clinical site and preserved for a further use
Cellular contents are meticulously washed out using detergents, DNAase, and saline solutions
Formed decellularized mash is dispersed within the chaotropic solution, containing surfactants in order to generate the dispersion.
The additives are washed out and the basal medium is added in order to generate the most biocompatible product
Controls
DNA content
AFM-based visualisation
Gelation efficiency
Biocompatibility
Lipid content
Protein integrity